AUDREY MORGAN: Open Payments
NPI 1811339252 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,251 in 260 payments from 34 companies in 2025. Trend: 2023 $4,891 · 2024 $5,485 · 2025 $5,251
Food & beverage: $5,181Education: $70
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 30 | $601 |
| PFIZER INC. | 31 | $580 |
| ABBVIE INC. | 23 | $422 |
| Neurocrine BioSciences, Inc. | 18 | $402 |
| Lundbeck LLC | 14 | $300 |
| Amgen Inc. | 16 | $272 |
| ARGENX US, INC. | 12 | $244 |
| Otsuka America Pharmaceutical, Inc. | 7 | $230 |
| ACADIA Pharmaceuticals Inc | 11 | $216 |
| SK Life Science, Inc. | 7 | $197 |
Products named: NURTEC ODT, INGREZZA, Briviact, REXULTI, VYEPTI, NUPLAZID, UPLIZNA, HYQVIA.
Industry payments across AL — which companies pay providers there.
